Skip to main content
FRSX
NASDAQ Technology

Foresight to Voluntarily Delist from Tel Aviv Stock Exchange; Nasdaq Listing Unaffected

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Automotive Stocks · Consumer
Sentiment info
Neutral
Importance info
8
Price
$1.09
Mkt Cap
$5.963M
52W Low
$1.03
52W High
$7.95
52W Position info
5.8% above low
Off High info
86% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

FRSX is trading near its 52-week low of $1.03 (5.8% above the low) on light trading volume (0.2× avg).

Summary

Foresight announced voluntary delisting from the Tel Aviv Stock Exchange effective January 4, 2027, while ADSs continue trading on Nasdaq. The move reduces dual-listing costs and focuses investor relations on the U.S. market.


Key Events · Corporate Governance and Compliance · FRSX

  • Voluntary TASE Delisting Announced

    Foresight will delist its ordinary shares from the Tel Aviv Stock Exchange, with last trading day January 1, 2027 and delisting effective January 4, 2027.

  • Nasdaq Listing Unaffected

    ADSs will continue trading on Nasdaq under symbol FRSX; each ADS represents 90 ordinary shares. The company reports no technical or substantive impediment to continued Nasdaq trading.

  • Conversion Process for TASE Holders

    TASE holders may convert ordinary shares into ADSs through banks or brokers by depositing shares with Bank of New York Mellon; no fractional ADSs will be issued.

  • Cost Reduction Rationale

    Delisting is expected to reduce cost and administrative complexity of dual listing, allowing focus of investor-relations and capital-markets resources on Nasdaq.


Analysis · FRSX · Technology

Foresight is voluntarily delisting its ordinary shares from the Tel Aviv Stock Exchange, with the last trading day set for January 1, 2027 and delisting effective January 4, 2027. The move consolidates trading on Nasdaq, where most volume already occurs, and reduces dual-listing costs and administrative burden. The company faces a going concern warning and Nasdaq delisting risk disclosed in its Q2 2026 results on August 14, 2026, making this consolidation a strategic step to focus capital-markets resources on its primary U.S. listing. TASE holders can convert ordinary shares into ADSs (each representing 90 ordinary shares) through Bank of New York Mellon, with no fractional ADSs issued.

How filings like this one have moved

In the 30 days to Sep 30, 2026, 34.9% of the 1009 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.52%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, FRSX was trading at $1.09 on NASDAQ in the Technology sector, with a market capitalization of approximately $6M. The 52-week trading range was $1.03 to $7.95. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FRSX - Latest Insights

FRSX
Sep 28, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
7
FRSX
Aug 14, 2026, 4:06 PM EDT
Filing Type: 6-K
Importance Score:
8
FRSX
Jul 27, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
7
FRSX
Jun 15, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
10
FRSX
Jun 08, 2026, 9:00 AM EDT
Filing Type: 6-K
Importance Score:
9